TheProfitWatch

ROIV - Roivant Sciences Ltd. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
16.75 0.29 (1.73%) --- --- 0.0 (0.0%) 0.0 (0.0%) 0.44 (2.66%) 0.06 (0.35%) 0.06 (0.35%)

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.33
Diluted EPS:
-0.33
Basic P/E:
-51.6364
Diluted P/E:
-51.6364
RSI(14) 1m:
0.0
VWAP:
17.04
RVol:
1.1098

Events

Period Kind Movement Occurred At

Related News